US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist
  • 0.008700
  • -0.001500-14.71%
15min DelayClose Nov 27 16:00 ET
270.67KMarket Cap0.03P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
Total revenue
0
40.64K
89.44K
1,269.13%410.17K
233.80%100K
310.17K
0
0
29.96K
29.96K
Operating revenue
--0
--40.64K
--89.44K
1,269.13%410.17K
233.80%100K
--310.17K
--0
--0
--29.96K
--29.96K
Cost of revenue
6.22K
0
Gross profit
34.42K
0
Operating expense
-68.49%152.28K
-3.67%240.85K
-24.64%261.34K
-55.04%1.34M
-48.56%261.5K
-23.90%483.25K
-65.76%250.01K
-68.77%346.79K
14.76%2.98M
-14.76%508.31K
Selling and administrative expenses
-50.31%109.39K
-43.77%133.65K
-47.55%148.92K
-49.46%909.98K
-51.19%168.26K
-42.96%220.13K
-40.53%237.68K
-57.65%283.9K
117.30%1.8M
175.06%344.71K
-Selling and marketing expense
----
----
----
-92.35%1.22K
----
----
----
----
-21.08%15.98K
----
-General and administrative expense
-50.31%109.39K
-43.77%133.65K
-47.55%148.92K
-49.08%908.76K
-49.19%167.04K
-42.96%220.13K
-40.53%237.68K
-57.65%283.9K
120.77%1.78M
212.85%328.74K
Research and development costs
-83.70%42.88K
769.56%107.2K
78.76%112.42K
-63.53%431.57K
-43.01%93.24K
5.64%263.12K
-96.27%12.33K
-85.71%62.89K
-33.21%1.18M
-65.27%163.6K
Operating profit
12.02%-152.28K
17.43%-206.43K
50.43%-171.9K
68.47%-931.38K
66.24%-161.5K
72.74%-173.08K
65.76%-250.01K
68.77%-346.79K
-13.61%-2.95M
19.78%-478.35K
Net non-operating interest income expense
17.69%21.65K
-77.70%4.68K
39.12%-6.62K
7.78%-1.17K
96.14%-29.67K
-60.57%18.39K
104.13%20.99K
94.88%-10.88K
97.93%-1.27K
-219.44%-769.2K
Non-operating interest expense
----
----
-39.12%6.62K
-7.78%1.17K
----
----
----
-94.88%10.88K
-46.76%1.27K
----
Total other finance cost
-17.69%-21.65K
77.70%-4.68K
----
----
----
60.57%-18.39K
-104.13%-20.99K
----
----
----
Other net income (expense)
94.84%-123.71K
-93.28%-2.78M
-382.38K
-2.4M
-169.69%-1.44M
Gain on sale of security
----
----
----
105.74%3.36K
----
----
----
----
-133.66%-58.57K
----
Special income (charges)
--0
94.84%-123.71K
----
-315.37%-2.73M
49.58%-330.93K
--0
---2.4M
----
---656.33K
-234.92%-656.33K
-Gain on sale of property,plant,equipment
--0
94.84%-123.71K
----
-315.37%-2.73M
49.58%-330.93K
--0
---2.4M
----
---656.33K
-234.92%-656.33K
Other non- operating income (expenses)
----
----
----
92.41%-54.81K
----
----
----
----
-2.17%-722.24K
----
Income before tax
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
78.64%-573.55K
73.71%-154.69K
-111.83%-2.62M
72.97%-357.67K
-37.50%-4.39M
-294.14%-2.68M
Income tax
Net income
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-37.50%-4.39M
-68.66%-1.15M
Net income continuous Operations
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-37.50%-4.39M
-68.66%-1.15M
Minority interest income
Net income attributable to the parent company
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-37.50%-4.39M
-68.66%-1.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-37.50%-4.39M
-68.66%-1.15M
Basic earnings per share
79.01%-0.0042
99.25%-0.01
99.70%-0.001
88.30%-0.42
97.30%-0.0254
96.37%-0.02
-31.68%-1.33
72.50%-0.33
-49.58%-3.59
-394.74%-0.94
Diluted earnings per share
79.01%-0.0042
99.25%-0.01
99.70%-0.001
88.30%-0.42
97.30%-0.0254
96.37%-0.02
-31.68%-1.33
72.50%-0.33
-49.58%-3.59
-394.74%-0.94
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022
Total revenue 040.64K89.44K1,269.13%410.17K233.80%100K310.17K0029.96K29.96K
Operating revenue --0--40.64K--89.44K1,269.13%410.17K233.80%100K--310.17K--0--0--29.96K--29.96K
Cost of revenue 6.22K0
Gross profit 34.42K0
Operating expense -68.49%152.28K-3.67%240.85K-24.64%261.34K-55.04%1.34M-48.56%261.5K-23.90%483.25K-65.76%250.01K-68.77%346.79K14.76%2.98M-14.76%508.31K
Selling and administrative expenses -50.31%109.39K-43.77%133.65K-47.55%148.92K-49.46%909.98K-51.19%168.26K-42.96%220.13K-40.53%237.68K-57.65%283.9K117.30%1.8M175.06%344.71K
-Selling and marketing expense -------------92.35%1.22K-----------------21.08%15.98K----
-General and administrative expense -50.31%109.39K-43.77%133.65K-47.55%148.92K-49.08%908.76K-49.19%167.04K-42.96%220.13K-40.53%237.68K-57.65%283.9K120.77%1.78M212.85%328.74K
Research and development costs -83.70%42.88K769.56%107.2K78.76%112.42K-63.53%431.57K-43.01%93.24K5.64%263.12K-96.27%12.33K-85.71%62.89K-33.21%1.18M-65.27%163.6K
Operating profit 12.02%-152.28K17.43%-206.43K50.43%-171.9K68.47%-931.38K66.24%-161.5K72.74%-173.08K65.76%-250.01K68.77%-346.79K-13.61%-2.95M19.78%-478.35K
Net non-operating interest income expense 17.69%21.65K-77.70%4.68K39.12%-6.62K7.78%-1.17K96.14%-29.67K-60.57%18.39K104.13%20.99K94.88%-10.88K97.93%-1.27K-219.44%-769.2K
Non-operating interest expense ---------39.12%6.62K-7.78%1.17K-------------94.88%10.88K-46.76%1.27K----
Total other finance cost -17.69%-21.65K77.70%-4.68K------------60.57%-18.39K-104.13%-20.99K------------
Other net income (expense) 94.84%-123.71K-93.28%-2.78M-382.38K-2.4M-169.69%-1.44M
Gain on sale of security ------------105.74%3.36K-----------------133.66%-58.57K----
Special income (charges) --094.84%-123.71K-----315.37%-2.73M49.58%-330.93K--0---2.4M-------656.33K-234.92%-656.33K
-Gain on sale of property,plant,equipment --094.84%-123.71K-----315.37%-2.73M49.58%-330.93K--0---2.4M-------656.33K-234.92%-656.33K
Other non- operating income (expenses) ------------92.41%-54.81K-----------------2.17%-722.24K----
Income before tax 15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M78.64%-573.55K73.71%-154.69K-111.83%-2.62M72.97%-357.67K-37.50%-4.39M-294.14%-2.68M
Income tax
Net income 15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-37.50%-4.39M-68.66%-1.15M
Net income continuous Operations 15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-37.50%-4.39M-68.66%-1.15M
Minority interest income
Net income attributable to the parent company 15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-37.50%-4.39M-68.66%-1.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-37.50%-4.39M-68.66%-1.15M
Basic earnings per share 79.01%-0.004299.25%-0.0199.70%-0.00188.30%-0.4297.30%-0.025496.37%-0.02-31.68%-1.3372.50%-0.33-49.58%-3.59-394.74%-0.94
Diluted earnings per share 79.01%-0.004299.25%-0.0199.70%-0.00188.30%-0.4297.30%-0.025496.37%-0.02-31.68%-1.3372.50%-0.33-49.58%-3.59-394.74%-0.94
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data